CO4940453A1 - Nuevo metodo de tratamiento con agente antihiperglucemicos inhibidores de alfaglucosida- sa para tratamiento de diabetes - Google Patents
Nuevo metodo de tratamiento con agente antihiperglucemicos inhibidores de alfaglucosida- sa para tratamiento de diabetesInfo
- Publication number
- CO4940453A1 CO4940453A1 CO98034648A CO98034648A CO4940453A1 CO 4940453 A1 CO4940453 A1 CO 4940453A1 CO 98034648 A CO98034648 A CO 98034648A CO 98034648 A CO98034648 A CO 98034648A CO 4940453 A1 CO4940453 A1 CO 4940453A1
- Authority
- CO
- Colombia
- Prior art keywords
- treatment
- alfaglucosida
- diabetes
- new method
- hyperglycemic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4940453A1 true CO4940453A1 (es) | 2000-07-24 |
Family
ID=26311746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98034648A CO4940453A1 (es) | 1997-06-18 | 1998-06-18 | Nuevo metodo de tratamiento con agente antihiperglucemicos inhibidores de alfaglucosida- sa para tratamiento de diabetes |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0975343A1 (fr) |
JP (1) | JP2001523271A (fr) |
KR (1) | KR20010013845A (fr) |
CN (1) | CN1274282A (fr) |
AP (1) | AP9901720A0 (fr) |
AR (2) | AR013352A1 (fr) |
AU (1) | AU8799998A (fr) |
BG (1) | BG103966A (fr) |
BR (1) | BR9810186A (fr) |
CA (1) | CA2294134A1 (fr) |
CO (1) | CO4940453A1 (fr) |
DZ (1) | DZ2519A1 (fr) |
EA (1) | EA200000040A1 (fr) |
IL (1) | IL133138A0 (fr) |
MA (1) | MA26510A1 (fr) |
NO (1) | NO996270D0 (fr) |
NZ (1) | NZ501345A (fr) |
OA (1) | OA11631A (fr) |
PE (1) | PE89199A1 (fr) |
PL (1) | PL337577A1 (fr) |
SK (1) | SK179499A3 (fr) |
TR (1) | TR199903072T2 (fr) |
UY (1) | UY25051A1 (fr) |
WO (1) | WO1998057635A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL351686A1 (en) | 1999-04-23 | 2003-06-02 | Smithkline Beecham Plc | Novel pharmaceutical |
WO2002080936A1 (fr) | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Polytherapie comprenant des inhibiteurs de reabsorption du glucose et des modulateurs ppar |
DE60233655D1 (de) | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R und retinoid x rezeptorenmodulatoren |
FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
JP2004067575A (ja) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | 糖尿病治療薬効果促進剤 |
CN101121004B (zh) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | 含有胰岛素增敏剂和米格列醇的药物组合物 |
CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900435A (en) * | 1991-08-26 | 1999-05-04 | Pharmacia & Upjohn Company | Composition, food product and uses of 3-guanidinopropionic acid |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/fr not_active Withdrawn
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Application Discontinuation
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/fr not_active Application Discontinuation
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/fr not_active Abandoned
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/fr active
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ501345A (en) | 2001-10-26 |
UY25051A1 (es) | 2000-09-29 |
NO996270L (no) | 1999-12-17 |
DZ2519A1 (fr) | 2003-02-01 |
AR014881A1 (es) | 2001-04-11 |
TR199903072T2 (xx) | 2000-07-21 |
OA11631A (en) | 2004-11-22 |
KR20010013845A (ko) | 2001-02-26 |
AR013352A1 (es) | 2000-12-27 |
NO996270D0 (no) | 1999-12-17 |
BG103966A (bg) | 2000-07-31 |
BR9810186A (pt) | 2000-08-08 |
MA26510A1 (fr) | 2004-12-20 |
SK179499A3 (en) | 2000-11-07 |
EA200000040A1 (ru) | 2000-08-28 |
CA2294134A1 (fr) | 1998-12-23 |
EP0975343A1 (fr) | 2000-02-02 |
IL133138A0 (en) | 2001-03-19 |
WO1998057635A1 (fr) | 1998-12-23 |
JP2001523271A (ja) | 2001-11-20 |
PE89199A1 (es) | 1999-10-23 |
CN1274282A (zh) | 2000-11-22 |
PL337577A1 (en) | 2000-08-28 |
AP9901720A0 (en) | 1999-12-31 |
AU8799998A (en) | 1999-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2012015I1 (no) | Dapoxetine i en hver form beskyttet av basis patent nr 330562 | |
BR0111800A (pt) | Combinações de inibidores de depeptidil peptidase iv e outros agentes antidiabéticos para o tratamento de diabete mellitus | |
BR0111196A (pt) | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus | |
EA200100002A1 (ru) | Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурхолата | |
SE9404196D0 (sv) | New antithrombotic formulation | |
ES2549551T1 (es) | Método de aumentar la dureza y la rigidez ósea y de reducir las fracturas | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
DE60108489D1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
AR018357A1 (es) | Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos | |
ES2185660T3 (es) | Nuevo uso de dexmedetomidina. | |
BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
CO4940453A1 (es) | Nuevo metodo de tratamiento con agente antihiperglucemicos inhibidores de alfaglucosida- sa para tratamiento de diabetes | |
AR043660A1 (es) | El tratamiento de la enfermedad de alzheimer | |
PL333059A1 (en) | Pharmaceutic agent containing adamantamines or structurally similar compounds for fighting against the borna disease virus (bdv) disease and preventing affective diseases as well as other diseases associated with bdv infections | |
AR019327A1 (es) | Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana | |
BR9810292A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase | |
IT1295954B1 (it) | Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti | |
PT774961E (pt) | Utilizacao de selegilina para o tratamento de doencas epilepticas | |
EA200100041A1 (ru) | Способ лечения | |
BR0317772A (pt) | Método de tratamento de um distúrbio de comportamento, uso de um composto, e, agente terapêutico para um distúrbio de comportamento | |
UY26735A1 (es) | Métodos y composiciones para tratar flavivirus y pestivirus | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
ES2025787T3 (es) | Procedimiento de tratamiento de madera. | |
CO5270004A1 (es) | Composiciones farmaceuticas con agente del tipo biguanida para tratamientos en diabetes | |
AR009470A1 (es) | COMPOSICIoN FARMACÉUTICA QUE CONTIENE CEPAS BACTERIANAS Y UTILES EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS CON O CAUSADAS POR ALTERACIONES EN EL METABOLISMO DE LOS ÁCIDOS BILIARES, Y USO DE LAS MISMAS. |